The drug price control threat

Wall Street Journal

8 January 2019 - Trump, Sanders and Warren sound the same themes. Watch out.

For all the nasty partisan divisiveness in Washington, it’s often worth worrying more when both parties agree. 

A case in point is a potential left-right condominium on drug prices that should alarm Americans hoping a cure for cancer or Alzheimer’s arrives in their lifetime.

Read Wall Street Journal editorial (subscription required)

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing